Catherine THIEBLEMONT, MD
Saint-Louis Hospital, Paris, France · Hôpital Saint-louis, APHP, PARIS · Lymphoma Study Association
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Catherine THIEBLEMONT, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:47 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04333524 · FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic RoleInternational Extranodal Lymphoma Study Group (IELSG) · active not recruiting · Marginal Zone Lymphoma · study chair
- Ph2NCT04113226 · Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell LymphomaCentre Hospitalier Universitaire, Amiens · completed · Chemotherapy, Diffuse Large B-Cell Lymphoma (DLBCL), Nos, Elderly · principal investigator
- Ph2NCT03697512 · MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone LymphomasInternational Extranodal Lymphoma Study Group (IELSG) · active not recruiting · Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma · study chair
- Ph2NCT00847223 · Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell LymphomaLymphoma Study Association · terminated · Mantle Cell Lymphoma · study chair
- Ph3NCT00210353 · Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · completed · Lymphoma, Mucosa-Associated Lymphoid Tissue · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.